|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||
| Variable Interest Entity, Not Primary Beneficiary | ||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||
| Restricted cash | ||||||||||||||||||
| Due from affiliates | ||||||||||||||||||
| Total due from affiliates | ||||||||||||||||||
| Investments (includes assets pledged of $— and $603,322 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Total investments (includes assets pledged of $— and $603,322 as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Right-of-use assets | ||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||
| Variable Interest Entity, Not Primary Beneficiary | ||||||||||||||||||
| Total other assets | ||||||||||||||||||
| Assets held in Trust Accounts | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||
| Liabilities | ||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||
| Due to affiliates | ||||||||||||||||||
| Total due to affiliates | ||||||||||||||||||
| Debt obligations | ||||||||||||||||||
| Accrued performance allocation compensation | ||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||
| Total operating lease liabilities | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Consolidated Entity, Excluding VIE | ||||||||||||||||||
| Variable Interest Entity, Not Primary Beneficiary | ||||||||||||||||||
| Total other liabilities | ||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||
| Variable Interest Entity, Not Primary Beneficiary | ||||||||||||||||||
| Deferred underwriting | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Redeemable equity attributable to consolidated Public SPACs | ||||||||||||||||||
| Equity | ||||||||||||||||||
| Common stock, value, issued | ||||||||||||||||||
| Class A Common Stock | ||||||||||||||||||
| Class B Common Stock | ||||||||||||||||||
| Preferred stock, $0.001 par value, 25,000,000 shares authorized (0 issued and outstanding as of June 30, 2026 and December 31, 2025) | ||||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||
| Accumulated other comprehensive income, net of tax | ||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||
| Total equity | ||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||
Loading...